Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Benign prostatic hypertrophy: the therapeutic options].

F Pagano1, F Zattoni, F Vianello

  • 1Istituto di Urologia, Università, Padova.

Recenti Progressi in Medicina
|December 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Caprine herpes virus-1 reduces cell viability and enhances chemosensitivity in breast cancer cells.

Frontiers in oncology·2025
Same author

External validation of nomograms including MRI features for the prediction of side-specific extraprostatic extension.

Prostate cancer and prostatic diseases·2023
Same author

Reduction in broad-spectrum antimicrobial prescriptions by primary care pediatricians following a multifaceted antimicrobial stewardship program.

Frontiers in pediatrics·2023
Same author

Concept Development of an On-Chip PET System.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2022
Same author

Highly luminescent scintillating hetero-ligand MOF nanocrystals with engineered Stokes shift for photonic applications.

Nature communications·2022
Same author

Deep Learning for Predicting Gamma-Ray Interaction Positions in LYSO Detector.

Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference·2021
Same journal

Recenti progressi in medicina·2026
Same journal

Recenti progressi in medicina·2026
Same journal

Recenti progressi in medicina·2026
Same journal

Recenti progressi in medicina·2026
Same journal

Recenti progressi in medicina·2026
Same journal

Recenti progressi in medicina·2026
See all related articles

Benign prostatic hyperplasia (BPH) is common in aging males. Current BPH treatments range from transurethral resection to minimally invasive options and medications like alpha-blockers.

Area of Science:

  • Urology
  • Geriatrics
  • Pharmacology

Context:

  • Benign prostatic hyperplasia (BPH) is a prevalent condition in aging males.
  • The incidence of BPH increases with age, necessitating effective treatment strategies.
  • Transurethral resection of the prostate (TURP) remains the established gold standard for BPH management.

Purpose:

  • To review and evaluate current and emerging treatment strategies for benign prostatic hyperplasia (BPH).
  • To compare alternative BPH therapies against the established standard of care (TURP).
  • To assess the potential of minimally invasive treatments and pharmacotherapy in BPH management.

Summary:

  • BPH treatment evaluation focuses on comparing various strategies to the gold standard, transurethral resection of the prostate (TURP).

Related Experiment Videos

  • Minimally invasive treatments like thermotherapy, prostate dilatation, and intraprostatic stents are emerging alternatives, though their long-term significance requires further evaluation.
  • Medical treatments have evolved from phytotherapeutic agents to alpha-blockers and 5-alpha reductase blockers, showing promising therapeutic potential.

    • Impact:

    • Provides a comprehensive overview of BPH treatment options for clinicians and researchers.
    • Highlights the evolving landscape of BPH management, including the role of minimally invasive procedures and pharmacotherapy.
    • Informs clinical decision-making regarding the selection of appropriate BPH therapies based on efficacy and patient factors.